[{"Assets_0_Q3_USD":313093000.0,"CommonStockSharesOutstanding_0_Q3_shares":26187531.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-96428000.0,"NetIncomeLoss_3_Q3_USD":-129097000.0,"NetIncomeLoss_1_Q3_USD":-45219000.0,"StockholdersEquity_0_Q3_USD":278096000.0,"Ticker":"ESPR","CIK":"1434868","name":"ESPERION THERAPEUTICS, INC.","OfficialName":"Esperion Therapeutics Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"302940173.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171107"}]